Abstract
Against pandemic influenza A (H1N1) 2009, anti-influenza drugs were useful to save the disease aggravation and reduce the mortality. In addition to the existing anti-influenza drugs, novel drugs, including neuraminidase inhibitors (peramivir and laninamivir) and RNA polymerase inhibitors (favipiravir), also have clinical potentials to suppress pandemic influenza A (H1N1) 2009 virus as well as seasonal influenza virus.
| Original language | English |
|---|---|
| Pages (from-to) | 1685-1689 |
| Number of pages | 5 |
| Journal | Nippon rinsho. Japanese journal of clinical medicine |
| Volume | 68 |
| Issue number | 9 |
| Publication status | Published - 2010 Sept |
ASJC Scopus subject areas
- Medicine(all)